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Abstract
Neurodevelopmental disorders (NDDs) represent a diverse group of syndromes characterized by 
abnormal development of the central nervous system and whose symptomatology includes 
cognitive, emotional, sensory, and motor impairments. The identification of causative genetic 
defects has allowed for creation of transgenic NDD mouse models that have revealed 
pathophysiological mechanisms of disease phenotypes in a neural circuit- and cell type-specific 
manner. Mouse models of several syndromes, including Rett syndrome, Fragile X syndrome, 
Angelman syndrome, Neurofibromatosis type 1, etc., exhibit abnormalities in the structure and 
function of dopaminergic circuitry, which regulates motivation, motor behavior, sociability, 
attention, and executive function. Recent advances in technologies for functional circuit mapping, 
including tissue clearing, viral vector-based tracing methods, and optical readouts of neural 
activity, have refined our knowledge of dopaminergic circuits in unperturbed states, yet these tools 
have not been widely applied to NDD research. Here, we will review recent findings exploring 
dopaminergic function in NDD models and discuss the promise of new tools to probe NDD 
pathophysiology in these circuits.
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Introduction
In the last decade, the widespread adoption of technologies for functional circuit mapping in 
animal models has greatly enhanced our ability to understand the input-output relationships 
between populations of neurons and determine their function in vivo. These include 
techniques for the visualization, reconstruction, and analysis of intact circuits across micro- 
and macroscales. Examples include serial section electron microscopy [1,2], the Brainbow 
toolkit [3,4] and intersectional labelling strategies [5,6], improved neuroinformatic tools for 
neurite tracing [7], tissue clearing [8,9], light sheet microscopy [10,11], and serial two-
photon tomography [12,13]. Additionally, optogenetic [14] and chemogenetic [15] actuators, 
genetically encoded indicators of neuronal activity [16,17], and advanced in vivo imaging 
modalities [18–23] have allowed for the functional deconstruction of genetically defined 
circuits in order to probe their contributions to complex behaviors. The development of viral 
vectors that can deliver transgenes in a pathway- and cell type-specific manner [24–28] or 
broadly transduce neurons across the CNS [29] have greatly facilitated efforts to 
anatomically and functionally characterize complex neurobiological systems in both basal 
and disease states.
New tools for ‘connectomic’ or circuit-centered research that can survey large scale 
functional connectivity patterns are particularly well suited to the study of 
neurodevelopmental disorders (NDDs), such as autism spectrum disorder (ASD), where 
diverse genetic and environmental insults during neurodevelopment can vastly perturb 
circuit architecture and physiology across brain areas [30,31]. While the neural substrates of 
ASD symptomatology are multifaceted, mesencephalic dopamine systems, consisting of A8 
retrorubral, A9 nigrostriatal, and A10 mesocorticolimbic projections [32], represent circuits 
of interest given their potential contribution to several common ASD symptoms, including 
perseverant interests, stereotyped movements, impaired attention and executive function, and 
difficulty with social interactions [33]. Several recent studies implicate these circuits in 
behavioral phenotypes observed in rodent NDD disease models, including Angelman 
syndrome (AS), Rett syndrome (RS), fragile X syndrome (FXS), neurofibromatosis type 1 
(NF1), etc. (Table 1), yet widespread adoption of new tools for functional circuit mapping 
has yet to occur in these models. In this review, we will highlight common patterns of 
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cellular and circuit level phenotypic variation across NDD mouse models and discuss the 
promise of recent neurotechnological advances such as whole brain tissue clearing and gene 
delivery by systemic viral vectors to further elucidate NDD pathophysiology in 
dopaminergic circuits.
Elucidating abnormal patterns of dopaminergic connectivity in NDD models
Dopaminergic projection neurons are a heterogenous population whose function, activity, 
neurotransmitter content, and pattern of connectivity varies with brain region and connection 
target [34–36]. For example, efferents arising from the midbrain ventral tegmental area 
(VTA) project throughout the extended amygdala [including the nucleus accumbens (NAc)], 
hippocampus, and prefrontal cortex (the mesocorticolimbic pathway) and have been widely 
studied for their role in cognition, reinforcement, and motivation [37,38], while 
dopaminergic populations in the substantia nigra pars compacta (SNc) project primarily to 
the dorsal striatum (nigrostriatal pathway) and are critical for the selection and execution of 
motor programs and habitual behavior [39,40]. Other populations outside the mesencephalon 
include those in the dorsal raphe nucleus (DRN)/ventral periaqueductal gray area (vPAG) 
that affect social behavior, nociception, and arousal [41–43] and tuberoinfundibular 
projections from the hypothalamic arcuate nucleus to the median eminence that regulate 
prolactin release [44].
Mesencephalic dopaminergic neurons in mice arise from a pool of progenitors in the 
midbrain floor plate under the control of numerous signaling molecules, including sonic 
hedgehog, WNT1, engrailed 1 and 2, fibroblast growth factor-8, etc., undergo radial 
migration to their final positions in either the VTA or SNc by embryonic day 13.5, and 
exhibit extensive axonal outgrowth along the anteroposterior and dorsoventral axes with 
synaptogenesis in downstream targets continuing into postnatal development [45]. 
Consequently loss of NDD-associated genes, such as EN2, MECP2, CNTNAP2, and NF1, 
produce hypo- or hyperdopaminergic behavioral phenotypes, such as abnormal motor, 
cognitive, or social behavior, in mouse models by perturbing neuronal maturation, 
migration, or neurite outgrowth [46–53]. Efforts to understand these phenotypes would 
benefit from a comprehensive ultrastructural understanding of how specific NDD-associated 
genetic changes alter dopaminergic circuit architecture and function and inform new 
therapeutic strategies, such as whole brain gene therapy or genome editing, to help 
ameliorate NDD symptomatology.
Several recent viral vector-based labeling methods are likely to greatly enhance our 
understanding of the input-output relationship between dopaminergic efferent and afferent 
connections in NDD models (Table 2A). This toolkit includes a new adenoassociated viral 
(AAV) vector for retrograde labeling (AAV2-retro) [26] (in addition to existing retrograde 
labeling vectors [24,25,27]), intersectional strategies to target individual neuronal 
projections and their inputs (INTERSECT [5], TRIO [6]), mGRASP for fluorescent labeling 
of connections between synaptic partners [54,55], and a single cell projection mapping via 
RNA barcoding (MAP-seq [56]). The recently developed brain-penetrant AAV PHP.eB can 
efficiently deliver viral transgenes to the CNS after peripheral administration (Figure 1A–B) 
[29,57], including Brainbow reagents [58] for multicolor labeling via stochastic expression 
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of fluorescent proteins (XFPs) [57] and genetically encoded calcium indicators (GECIs; 
[59,60]). This tool should also prove useful for non-invasive delivery of optogenetic [14] or 
chemogenetic [15] tools, AAV-optimized CRISPR-Cas9 effectors for genome editing (e.g. 
[61–63]), and therapeutic transgenes across large brain volumes. Additionally, PHP.eB can 
deliver the cargo of interest co-administered with a titratable inducer vector for controlled 
sparseness while maintaining high viral transgene copy number [57], which is beneficial for 
effective neurite tracing with methods such as mGRASP [55] or Brainbow [58] (Figure 1C–
D). This method is also likely to benefit sensors that need sparse expression to reduce 
background fluorescence [64–66].
The utility of viral vector-based mapping tools has been improved by microscopic 
techniques for rapid imaging of large samples, such as light sheet microscopy [11,67,68] or 
high-speed volumetric serial two-photon (STP) tomography [12] (Table 2B), and tissue 
clearing protocols that render biological samples optically transparent for analysis of intact 
circuits in whole brains or thick slices (Figure 2) [8,9]. Several tissue clearing strategies have 
been recently described or refined (Table 2C); these include immersion clearing with high 
refractive index (RI) solutions (SeeDB [69], FRUIT [70], RIMS [71]), clearing via 
hyperhydration (Sca/eS [72], CUBIC [73,74]), hydrogel embedding followed by detergent 
delipidation (CLARITY [75,76], PARS [77,78], PACT [77,78]), and solvent-based clearing 
methods (uDISCO [79]). Clearing methods that build upon water-absorbent CLARITY 
hydrogels to create hyperabsorbant hydrogels have also been implemented to facilitate high 
resolution imaging of small structures, such as individual dendrites or neurites (ExM [80–
82], ePACT [78], and MAP [83]). Hydrogel-based methods preserve endogenous 
fluorescence while maintaining compatibility with tools for proteomic analysis [76,78,82–
84], RNA profiling (smFISH or smHCR probes [71,81,85,86]), and time-stamped 
fluorescent readouts of neuronal activity (e.g. ArcTRAP [87,88]).
Several recent studies have successfully integrated these technologies to probe the structure 
of dopaminergic and related circuits in healthy mice. For example, retrograde labeling, tissue 
clearing, and LSM have been used to parse SNc subcircuit connectivity and function [89], 
identify an anatomically distinct projection to the posterior striatum [90] that preferentially 
encodes novel cue information rather than reward prediction errors [91], and refine our 
knowledge of cholinergic inputs to the SNc and VTA [92]. An input-output analysis of VTA 
connections using TRIO uncovered a novel projection from the anterior cingulate cortex to 
the lateral NAc that produces behavioral reinforcement using an optogenetic intracranial 
self-stimulation paradigm [93].
Bridging the gap between synaptic function and neural circuit dynamics in 
NDD models
One common feature amongst NDDs is that the causative genes (e.g. FMR1 in FXS, 
UBE3A in AS, MECP2 in RS, NF1 in NF1, EN1 and EN2, SHANK genes, etc.) affect 
synapse formation, maintenance, and plasticity in rodent models [94,95]. As such, there 
have been considerable efforts to characterize synapse function in dopaminergic circuits in 
these mice. For example, reduction in SHANK-3, an excitatory synapse scaffolding protein 
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whose loss of function is associated with Phelan McDermid Syndrome (also called 22q13 
deletion syndrome; see [96] for a review) and some non-syndromic ASD cases [97], via 
delivery of a short hairpin RNA (shRNA) into the VTA impairs maturation of excitatory 
synapses and reduces dopaminergic neuron excitability and social preference via increased 
inhibitory tone [98]. Mice modeling 15q11–13 Duplication Syndrome (where Ube3A 
protein levels are increased three-fold) exhibit a loss of sociability due to downregulation of 
the glutamatergic synapse organizer CBLN1 in the VTA [99]. Altered neurotransmitter 
content or release from VTA or SNc neurons in downstream targets has been reported in 
mouse models of AS [100,101], NF1 [46,47], and RS [52,102] and in Cntnap2 knockout 
mice [53]. While there is a large body of research delineating the role of synaptic or 
microcircuit deficits in NDD models [103–106], less is known about how those changes 
alter population dynamics or neuron ensemble activity to produce behavioral phenotypes; 
improvements in optical tools to monitor neural activity across multiple spatial scales 
[59,107–109] should help bridge this divide.
Understanding how networks of interconnected neurons encode and translate relevant 
environmental stimuli into a motivated behavior requires a high throughput readout of 
neuron firing with single-cell resolution. Metal electrodes or electrode arrays are a robust 
tool to measure spiking with high temporal precision and can be coupled with optogenetic 
tools to manipulate activity or infer cell identity (i.e. opto-tagging, [110]). Opto-tagging has 
been used to monitor diverse populations across the CNS (e.g. cortical interneurons 
[111,112], AgRP neurons in the arcuate nucleus [113], dopaminergic neurons in the VTA 
[114], etc.), yet this technique is limited in the number of neurons it can sample and may not 
be suitable for all populations due to the challenges in efficiently and accurately opto-
tagging (e.g. cortical pyramidal neurons), as well as genetically similar populations that are 
too sparse or dense to be reliably identified. In contrast, optogenetic stimulation of 
dopaminergic circuitry during blood oxygen level dependent contrast (BOLD) fMRI 
imaging can approximate mesocorticolimbic or nigrostriatal network activity in rodents 
[115–117], yet this technique lacks both cellular resolution and temporally precise 
neurophysiological readouts.
Alternatively, genetically encoded calcium indicators (GECIs; e.g. the GCaMP6 family of 
proteins [16]) provide cell type-specific fluorescent readouts of neuron activity during 
behavior that is stable over months of testing and is scalable [21]. Using two-photon 
mesoscopes with wide field of view objectives [108] or random access scanning strategies 
[107] to image through large cranial windows in head-fixed mice, researchers can record the 
calcium dynamics of hundreds to thousands of neurons at once. Bulk calcium signals can 
also be measured across superficial cortical areas using a wide field fluorescence 
macroscope featuring a 12 mm field of view, which has been used to assess global 
representations of motivated behavior in multiple cell types [59]. While these tools have 
been optimized for relatively superficial (< 1mm deep) structures, several tools should help 
extend the depth of non-invasive optical access, such as three-photon microscopy [118], the 
implementation of axially elongated Bessel foci [119], photoacoustic tomography [120], and 
guidestar-assisted wavefront engineering techniques to limit optical scattering [121], such as 
time reversal of ultrasound encoded light (TRUE) [122,123].
Robinson and Gradinaru Page 5
Curr Opin Neurobiol. Author manuscript; available in PMC 2019 February 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Several recent technologies have provided optical access to deep brain areas in behaving 
mice for activity measurements in bulk or with single-cell resolution. For bulk 
measurements, fiber photometry [124] and TEMPO [125] allow for quantification of 
calcium or voltage sensor dynamics, respectively, using implanted optical fibers in order to 
correlate activity of genetically defined populations with behavioral events. Calcium 
imaging via implanted gradient index microendoscopes (GRIN lenses) provides single cell 
resolution at depths >4mm below the skull surface [126]. While two-photon GRIN lens 
imaging is most commonly performed in head-fixed mice [127], several strategies such as 2-
photon fiberscopes [128,129] and miniaturized head-mounted 2-photon microscopes 
[130,131] have been developed for freely moving behavior. Head-mounted miniaturized 
epifluorescence microscopes [132] are also available and have been more widely adopted for 
use in behaving animals. Single cell calcium dynamics have been imaged via GRIN lens in 
the VTA [133], SNc [134], and interconnected regions, including the dorsal striatum [134], 
lateral hypothalamus [134,135], medial preoptic area [136], medial prefrontal cortex 
[137,138], bed nucleus of the stria terminalis [133], hippocampus [139,140], etc. 
Additionally, chronic imaging windows have permitted monitoring of sparsely labelled SNc 
axons in the dorsal striatum, which revealed distinct temporal and spatial encoding of reward 
and motor signals [39]. While several groups employ cortical two-photon calcium imaging 
in NDD models, including RS [141] and FXS [142] mice, analysis of deeper structures has 
not been reported to date.
Considerations and future outlook
The identification of causative genetic defects in neurodevelopmental syndromes and 
subsequent creation of transgenic mouse models has greatly enhanced our understanding of 
the developmental perturbations that produce synaptic, cellular, and behavioral phenotypes 
in these mice. While several recent studies examining dopaminergic circuitry have 
uncovered pathophysiological mechanisms underlying aberrant social interactions, positive 
reinforcement, stereotyped behavior, etc., few studies have employed new technologies for 
functional circuit mapping in NDD models. This may be due to several factors; first, given 
that phenotype expression is dependent on genetic background in many mouse models, such 
as NF1 [143], it will be important to continue identifying and developing minimal gene 
regulatory elements (promoters, enhancers, miRNA binding sites) that can be 
accommodated within well-tolerated viral capsids for cell type-specific targeting without the 
need to cross mice to Cre or Flp driver lines. Several cell type-specific promoters have been 
developed to target different cell populations in the CNS, including catecholaminergic 
(tyrosine hydroxylase promoter), serotonergic (FEV), Purkinje (PCP2) [144], and forebrain 
GABAergic (mDlx5/6) neurons [145], although they vary in leakiness and promoter size, 
which can limit packageable transgene size due to AAV carrying capacity of 4.7 kb [146]. 
Second, many of these techniques require specialized equipment, reagents, or expertise that 
makes implementation challenging. Several helpful imaging, tissue clearing, and data 
analysis protocols have recently been published [54,76,78,133,147–149] that can help guide 
potential users.
To effectively integrate measures of neural activity with comprehensive dopaminergic 
connectomes in mouse models obtained with such tools for precise structural and functional 
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analysis of intact circuits, several advances will be required. First, we will need better 
computational methods for automated detection, segmentation, and tracing of individual 
fluorescently labelled neurons in whole cleared brains. This task is currently labor intensive 
and works poorly for neurons with complex morphology, such as catecholaminergic neurons 
with large axonal arbors that traverse several mm of brain tissue. Recent successes in 
overcoming these challenges include the reconstruction of single projection neurons in the 
claustrum, which branch extensively throughout the entire cerebrum [150]. Second, we will 
need improved tools for converting neural activity states into fluorescent labels that can be 
superimposed upon neuronal reconstructions. Several technologies show promise, such as 
CaMPARI [151] and iTANGO [152], which provide light timestamped indicators of 
intracellular calcium or dopaminergic neurotransmission, respectively. Hybridization chain 
reaction (HCR) probes for single-cell, multiplexed RNA detection have been validated for 
hydrogel-based clearing methods [86,153] and could allow for medium throughput 
identification of projection- or activity-dependent changes in gene activity in mutant and 
wildtype mice. At this time, only PACT/PARS [71], EDC-CLARITY [86], and Ex-FISH 
[81] have been demonstrated to be compatible with RNA profiling, yet clearing methods are 
advancing rapidly and will likely be useful for a broader range of applications in the future.
When examining the role of functional circuit mapping technologies in elucidating 
dopaminergic connectivity in NDD models, one cannot neglect the ontogeny of these 
circuits. Several methods have been used to clear mouse embryos at various stages of 
development (reviewed by [154]), yet it is difficult to employ viral vector-based tracing and 
labeling techniques in the developing mouse. It is thus of great interest to identify AAVs that 
cross the blood-placenta barrier and selectively target the developing embryonic nervous 
system. AAV selection platforms, such as CREATE (Cre recombination–based AAV 
targeted evolution), which has been used to develop vectors that efficiently target the central 
(PHP.B/PHP.eB) or peripheral (PHP.S) nervous systems [29,57] when given systemically, 
could yield new vectors for in utero transgene delivery. Additionally, tools for large volume 
functional imaging of developing organisms, such as a two-beam light sheet microscope 
with adaptive optics and automated cell tracking [11], have been applied to early embryonic 
mice [155,156], yet new methods to maintain optical access within the amnion will be 
necessary to image and track post-implantation fetal cells.
Going forward, we anticipate that continued technological advances can yield progressively 
more precise and comprehensive functional and connectomic maps of dopaminergic 
circuitry across development. As these tools become more widely adopted by NDD 
researchers, we will likely gain newfound understanding of how functional and structural 
abnormalities synergize to produce behavioral and cognitive phenotypes in mouse models 
and reveal putative mechanisms of disease symptomatology in human populations. 
Ultimately these discoveries can inform the creation of behavioral and pharmacological 
therapies that target circuit- or cell-type specific mechanisms of disease in order to benefit 
the health of affected children and adults.
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Highlights
• Dopaminergic dysfunction is common in many neurodevelopmental 
disorders.
• New circuit mapping tools have refined our knowledge of these circuits at 
baseline.
• When used in animal models, these tools will likely elucidate NDD 
pathophysiology.
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Figure 1. Broadly transducing AAVs permit brainwide transgene expression and facilitate 
neurite tracing
A. Workflow for multicolor labelling with PHP.eB and neurite tracing. Viral particles 
carrying red, green, or blue XFP transgenes with or without a titratable inducer are 
systemically introduced via retro-orbital injection (1). Following transduction (4–8 weeks), 
brains are fixed and cleared (2). Tissue samples can then be imaged with light sheet or 
confocal microscopy (3) prior to neurite tracing (4). B. Brainwide transduction of neurons 
(green) or astrocytes (red) using cell type-specific promoters (hSyn1 and GFAP, 
respectively) and gene regulatory elements following retro-orbital injection of PHP.eB 
(1×1012 viral genomes/mouse). C–D. Sparsely labelled striatal neurons were successfully 
traced after transduction by PHP.eB multicolor XFPs.
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Figure 2. Visualization of intact circuits using hydrogel-based clearing methods
A. A mouse brain before and after clearing with PARS and long-term storage in RIMS 
(adapted from [71]). The sample demonstrates moderate tissue expansion due to acrylamide 
embedding. B. Confocal image of dopaminergic neurons in the SNc (red) and cholinergic 
afferents from the pedunculopontine tegmental nucleus (green) visualized in a 1mm-thick 
PACT-cleared section. C–D. Whole brain imaging of fluorescently-labelled cells in Thy1-
eYFP mice using light sheet microscopy.
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Table 1
Diverse behavioral, synaptic, and cellular phenotypes are observed in nigrostriatal and mesocorticolimbic 
pathways in mouse models of neurodevelopmental syndromes and ASD candidate genes.
Neurodevelopmental Syndromes
Syndrome Mouse Model Major Findings Citation
15q11–13 Duplication Syndrome Ube3a-2× Triplication of Ube3a 
synergizes with seizures to 
reduce expression of the 
glutamatergic synapse 
organizer Cbln1, impairs 
glutamatergic transmission 
in VTA neurons, and leads 
to loss of sociability.
[99]
16p11.2 Deletion Syndrome 16p11.2+/− Mice carrying a 
homologous chromosomal 
deletion to 16p11.2 (7F3) 
exhibit abnormal synaptic 
signaling and increased 
numbers of dopamine D2 
receptor (D2R)-expressing 
medium spiny neurons 
(MSNs) in the striatum, 
fewer D1 receptor (D1R)-
expressing neurons in the 
cortex, locomotor 
hyperactivity, and deficits in 
motor control.
[157]
Angelman Syndrome Ube3am−/p+ Ube3am−/p+ mice display 
enhanced electrically 
evoked dopamine release in 
the NAc and reward seeking 
but decreased sensitivity to 
drugs that increase 
dopamine overflow.
[100]
TH-Cre∷Ube3am−/p+, TH-Cre∷Ube3aFLOX/p+ Loss of maternal Ube3a in 
tyrosine hydroxylase (TH)-
expressing neurons 
enhanced optical self-
stimulation via increased 
GABA release from 
dopaminergic terminals in 
the NAc.
[101]
Fragile X Syndrome Fmr1−/y Fmr1−/y mice are more 
sensitive to the rewarding 
effects but less sensitive to 
the motor effects of cocaine 
compared to wildtype; the 
number of TH-expressing 
neurons in reduced in the 
SNc but not VTA of these 
mice.
[158]
Fmr1−/y Locomotor sensitization, 
conditioned place 
preference, and synaptic 
changes in the NAc 
following repeated cocaine 
is reduced in Fmr1−/y mice.
[159]
Neurofibromatosis Type 1 Nf1+/−:Nf1FLOX∷GFAP-Cre:Nf1FLOX/FLOX Mice with one non-
functional Nf1 allele in all 
somatic cells and complete 
Nf1 knockout in glial 
fibrillary acid protein 
(GFAP)-expressing cells 
display reduced striatal 
[47]
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Neurodevelopmental Syndromes
Syndrome Mouse Model Major Findings Citation
dopamine and TH 
expression in vivo and 
reduced dopaminergic 
neurite outgrowth in vitro.
Nf1+/−, TH-Cre∷Nf1FLOX/FLOX, GFAP-Cre∷GFAPFLOX/FLOX Knockout of Nf1 in TH or 
GFAP-expressing cells is 
associated with reduced 
dopamine content in the 
hippocampus and deficits in 
spatial working memory.
[46]
Rett Syndrome Mecp2+/−, Mecp2−/y SNc neurons exhibit 
decreased somal size, 
dendrite count, and striatal 
dopamine release in 
Mecp2+/− mice and 
symptomatic Mecp2−/y 
males.
[52]
Mecp2+/− Mecp2+/− display aberrant 
motor coordination and 
motor skill learning 
secondary to reduced 
striatal dopamine content, 
down-regulation of tyrosine 
hydroxylase expression, and 
dopamine D2 receptor 
(D2R) up-regulation.
[102]
Mecp2S421A Loss of MeCP2 
phosphorylation at position 
421 results in accelerated 
amphetamine sensitization 
and changes in MSN 
excitability in the NAc.
[160]
Dlx5/6-Cre∷DMecp2FLOX/y Conditional knockout of 
Mecp2 in the striatum 
phenocopies Mecp2+/− mice 
in dopamine deregulation 
and motor dysfunction.
[161]
Non-Syndromic ASD Genes
Gene (Product) Mouse Model Major Findings Citation
Cntnap4 (CNTNAP4) Cntnap4−/− Loss of Cntnap2 results in 
enhanced dopamine release 
in the NAc and dorsal 
striatum through a 
presynaptic mechanism and 
results in excessive 
grooming.
[53]
Nlgn1 (Neuroligin-1) Nlgn1−/− Nlgn1−/− display reduced 
GluN2A-containing NMDA 
receptor currents and 
glutmatergic inputs in 
dopamine D1 receptor 
(D1R) and D2R-expressing 
striatal medium spiny 
neurons (MSNs), 
respectively.
[162]
Nlgn2 (Neuroligin-2) Nlgn2 miR knockdown Striatal knockdown of 
Nlgn2 results in 
downregulation of 
dopaminergic synapses and 
upregulation of GABAergic 
synapses.
[163]
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Neurodevelopmental Syndromes
Syndrome Mouse Model Major Findings Citation
Nlgn3 (Neuroligin-3) Nlgn3−/−, Nlgn3R451C Both Nlgn3 knockout mice 
and mice modeling the 
R451C polymorphism 
demonstrate enhanced 
repetitive motor routines by 
impairing inhibitory 
transmission onto D1R-
expressing MSNs in the 
NAc.
[164]
Shank3 (SHANK3) (Note: loss of 
SHANK3 is also seen in Phelan 
McDermid Syndrome)
Shank3 shRNA knockdown Shank3 knockdown via 
short hairpin RNA (shRNA) 
in the VTA impairs 
excitatory synapse 
maturation, reduces 
dopaminergic neuron 
excitability via increased 
inhibitory tone, reduces 
social preference, and can 
be rescued an mGluR1 
agonist or optogenetic 
stimulation of dopaminergic 
neurons
[98]
Shank3b−/− Loss of Shank3b alters the 
development of excitatory 
inputs to medium spiny 
neurons of the dorsomedial 
striatum, which can be 
rescued by chemogenetic 
inhibition of corticostriatal 
inputs.
[165]
Shank3bfx/fx Loss of Shank3b in a 
conditional knock-in model 
results in abnormal motor, 
social and exploratory 
behaviors; repetitive 
grooming; and synaptic 
changes in the striatum. 
These deficits are rescued 
with germline re-activation 
of Shank3 expression.
[166]
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Table 2
Selected recent advances in neurotechnologies for structural analysis of circuit architecture in rodent models.
A. Viral Vectors and Vector-Based Labeling Methods
Tool Summary Citation
rAAV2-retro A recombinant AAV2 variant for retrograde targeting of projection neurons that can be used for 
both functional and tracing studies. Efficient retrograde transduction was observed in many 
cortical and subcortical regions.
[26]
PHP.eB and PHP.S AAV9-based vectors for efficient CNS (PHP.eB) or PNS (PHP.S) transduction after peripheral 
(intravenous or retro-orbital) virus administration. Can be used with a titratable inducer vector 
for controlled sparseness of multicolor labels that preserves color diversity; inducers involve use 
of tetracycline-controlled transactivator (tTA) or Cre-dependent Flp-based constructs.
[29,57]
TRIO Tracing the Relationship Between Input and Output; A combinatorial two-vector system that 
maps the input-output relationship of a population of neurons. In this method, canine 
adenovirus-2 (CAV-2) [25] is used to deliver a Flp recombinase transgene to axons in a specific 
projection terminal field for retrograde transduction of the cell bodies; Flp-dependent RVdG 
[24] component vectors are later delivered to the cell bodies for monosynaptic retrograde tracing 
of inputs. Cre-dependent Flp can be used for cell type-specific targeting using a Cre driver line 
(cTRIO). Cannot be used for functional studies due to lethality of RVdG.
[6]
INTERSECT INTronic Recombinase Sites Enabling Combinatory Targeting; A two-component system that 
allows for functional projection targeting using Flp- and Cre-dependent viral vectors via axonal 
targeting in a downstream region using replication incompetent herpes simplex virus (HSV) [27] 
carrying a Cre-dependent Flp recombinase transgene. Either Cre- and Flp-ON and -OFF 
strategies can be used.
[5]
MAP-Seq Multiplexed Analysis of Projections by Sequencing; allows for parallel mapping of single 
neuron axonal arbors via recovery of RNA barcodes in from terminal fields after delivery of 
AAV viral barcode libraries to the cell body. Does not distinguish fibers of passage, so 
downstream regions must be chosen carefully for RNA recovery and sequencing.
[56]
mGRASP Mammalian GFP Reconstitution Across Synaptic Partners; A method for fluorescently labeling 
synaptic connections that employs AAV-mediated delivery of synapse-targeted split GFP 
fragments in genetically defined pre- and post-synaptic neuronal partners. Cre-ON and Cre-OFF 
strategies can be used for studying microcircuits.
[54,55]
B. Large Volume Imaging Modalities
Light Sheet Microscopy 
(LSM)
Originally developed over 100 years ago, LSM illuminates the sample with a thin sheet of light 
and detects the emitted fluorescent signal with an orthogonally arranged detection objective. 
Variants include CLARITY optimized LSM (COLM) for use in cleared tissue [76], SPED 
(Spherical Aberration-assisted Extended Depth of Field) LSM that improves scan speed via 
extended depth of field [68], and an adaptive LSM that integrates multiple fields of view with 10 
degrees of freedom that are autonomously adjusted in real time for improved spatial resolution 
and image quality [11].
[10,11,68]
High-Speed Volumetric 
STP Tomography
High-speed Volumetric Serial Two-Photon Tomography; A high speed imaging platform based 
on Serial Two-Photon Tomography (STP) [13] that creates 3D reconstructions of neuronal 
axonal arbors via the integration of fast volumetric 2-photon microscopy and a vibrating 
microtome to image bright, sparsely labelled neurons in cleared samples embedded in gelatin. 
Includes computational tools for the registration and visualization of large (up to 100 TB) data 
sets, although labeling must be sufficiently sparse to prevent neurite reconstruction errors when 
axons from different neurons are closely positioned.
[12]
C. Tissue Clearing Methods
CLARITY Hydrogel-based clearing method that utilizes 4% SDS for lipid removal after sample has been 
embedded in an acrylamide-bisacrylamide gel and cross-linked with formaldehyde. Clearing can 
be accelerated with electrophoresis at the expense of tissue integrity. Compatible with 
immunolabeling and endogenous fluorescence. The EDC-CLARITY variant is compatible with 
HCR (hybridization chain reaction) probes for bulk RNA labeling.
[75,76,86]
PACT PACT-deCAL Passive CLARITY Technique; A passive CLARITY-based clearing method for rapid clearing of 
thick sections that employs 8% SDS as the detergent. Compatible with immunolabeling, 
endogenous fluorescence, smFISH (single molecule), and smHCR probes for single and bulk 
RNA labeling. Produces reversible expansion of tissue and can be used with RIMS (Reflective 
Index Matching Solution), a non-viscous mounting medium that decreases the refractive index 
of the sample for better optical access. PACT-deCAL uses EDTA/EGTA to decalcify samples for 
bone clearing.
[71,78,85,167]
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A. Viral Vectors and Vector-Based Labeling Methods
Tool Summary Citation
PARS Perfusion Assisted Agent Release In Situ; An active CLARITY-based clearing method that 
involves intracranial and/or transcardial perfusion of reagents for whole body clearing.
[71,78]
SWITCH System-Wide Control of Interaction Time and Kinetics of Chemicals; A fixation and clearing 
method that exploits the pH dependence of glutaraldehyde-tissue gel formation for uniform 
fixation prior to delipidation with SDS. This method provides added tissue integrity for 
multiplexed immunolabeling. Not compatible with smFISH or smHCR probes.
[84]
uDISCO A whole-body clearing method based on 3DISCO; it utilizes dehydration with tert-butanol 
followed by delipidation with diphenyl ether for fast sample clearing. Maintenance of 
endogenous fluorescence is improved relative to 3DISCO and other solvent based methods, 
whereby fluorescence deteriorates within several days after clearing. Shrinks tissues by 
approximately 40% for faster LSM imaging.
[79]
Sca/eS An improved version of Sca/eA2 [168] that achieves tissue transparency via partial delipidation 
and hyperhydration via urea, sorbitol, glycerol, and Triton X-100. Preserves endogenous 
fluorescence and limits expansion better than most other methods, although large0 sample 
clearing can take several weeks. A simplified protocol Sca/eSQ can be used in thick (<500 
micron) sections.
[72]
CUBIC Clear, Unobstructed, Brain/Body Imaging Cocktails and Computational Analysis; A clearing 
method based on Sca/eA2 that uses urea, aminoalcohols, TRITON X-100, and high sucrose 
concentrations. Maintains endogenous fluorescence, can be perfused for whole body clearing, 
produces reversible tissue expansion, and exhibits superior decolorization (i.e. loss of the heme 
chromophore) relative to other techniques.
[73,74]
Tissue Expansion Methods for High Resolution Microscopy
ExM Expansion Microscopy; A tissue expansion technology whereby the fixed and permeabilized 
sample is embedded in a superabsorbent hydrogel containing sodium acrylate and acrylamide, 
cross-linked with N-N′-methylenebisacrylamide, and digested with a protease to produce a 4.5-
fold sample expansion. Newer variants display improved protein retention (proExM) and are 
compatible with immunolabeling, smFISH, and smHCR (ExFISH).
[80–82]
ePACT Expansion PACT; Variant of the PACT tissue clearing method that utilizes a superabsorbent 
hydrogel and enzymatic digestion to increase sample size up to 5-fold for high resolution 
imaging with preserved endogenous fluorescence.
[78]
MAP Magnified Analysis of Proteome; a hydrogel-based clearing method that expands tissue without 
the use of enzymatic digestion via treatment with high acrylamide concentrations (up to 20%) 
prior to SDS treatment. Compatible with immunolabeling but not RNA detection.
[83]
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